S 95042
Alternative Names: S-95042Latest Information Update: 22 Dec 2023
At a glance
- Originator Servier
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Autoimmune disorders
Most Recent Events
- 28 Nov 2023 Preclinical trials in Autoimmune disorders in France (unspecified route) (Servier pipeline; November 2023)